Business Wire

Second Sight Medical Products Announces Year Four NIH Funding of its Orion Study

LOS ANGELES--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer of implantable visual prostheses that are intended to create an ...
Business Wire

Second Sight Receives Conditional FDA Approval to Begin First Orion Human Clinical Study

SYLMAR, Calif.--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to ...
MD&M East

All Eyes on Second Sight

It was February 14, 2013, when the call Robert Greenberg had been patiently awaiting finally came. On the line were two FDA officials calling with a Valentine’s Day gift, Greenberg, CEO of Second ...
Nasdaq

Second Sight Medical Products Announces Successful Completion of its Merger with Nano Precision Medical and its Name Change to Vivani Medical, Inc.

LOS ANGELES--(BUSINESS WIRE)-- Second Sight Medical Products, Inc.(NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer of implantable visual prosthetics that are intended to create an ...